We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Examine the Various Stages of the Regulatory Approval Process in the Life Sciences Industry

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Examine the Various Stages of the Regulatory Approval Process in the Life Sciences Industry"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Research and Markets has announced the addition of "Advising Clients on Regulatory Approvals in the Life Sciences Industry - The Over-Arching Issues You Need to Know (Executive Reports)" to their offering.

About Executive Reports:

Executive Reports offer focused, hard-hitting advice from the leaders of some of America's top companies, packaged in a concise, readable format.

Each research report provides readers with 3 to 5 strategies that will have a direct financial impact on their business.

While not meant as a comprehensive guide, each report includes quick-hit items that can immediately impact specific business strategies.

Executive authors drill down to the central issues surrounding each topic area and dispense expert advice in concise, direct language.

Executive Reports feature leading professionals selected by our Editorial Board, based on their experience, research, and standing within the professional community.

This 12-page summary report written for life science companies, walks its readers through the various stages of the regulatory approval process in the life sciences industry.

From product development and regulatory to the final marketing and approval stage, the report provides an in-depth look into the product information that is required at each stage.

Other topics include pharmaceuticals; FDA; Investigational New Drug applications; New Drug Applications; clinical trials; compliance; Congressional hearings; Federal Trade Commission; protecting intellectual property; and the political process.

This Executive Report is written by:

Diane J. Romza-Kutz, Managing Partner, Chicago & Stephen R. Drake, Attorney at Law, Epstein Becker & Green, P.C. - "Seeking Approval in the Life Sciences Industry"

Walt Addison Linscott, Esq., Managing Partner, Atlanta; Chair, Life Sciences Practice, Thompson Hine LLP - "The Regulatory Approval Process"